Basiliximab for the treatment of graft rejection in haploidentical peripheral blood stem cell transplantation

Haematologica. 2002 Dec;87(12):ECR44.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Basiliximab
  • Graft Rejection / drug therapy*
  • Haplotypes
  • Histocompatibility
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Leukemia, Myeloid, Acute / therapy
  • Leukemia, Myelomonocytic, Acute / therapy
  • Male
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • Recombinant Fusion Proteins*
  • Transplantation, Homologous / immunology

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Basiliximab